Technical Analysis for CYDY - Cytodyn Inc

Grade Last Price % Change Price Change
grade C 0.43 -1.78% -0.0078
CYDY closed down 1.78 percent on Friday, August 23, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical CYDY trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
NR7 Range Contraction 0.00%
50 DMA Resistance Bearish -1.78%
Crossed Above 20 DMA Bullish -1.78%
MACD Bullish Signal Line Cross Bullish -1.78%
Pocket Pivot Bullish Swing Setup 2.38%
Inside Day Range Contraction 2.38%
20 DMA Resistance Bearish 2.99%
MACD Bearish Signal Line Cross Bearish 2.99%

Older signals for CYDY ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
CytoDyn Inc. is a clinical-stage biotechnology company. The Company is focused on the clinical development and commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection. The Company's lead product candidate, PRO 140, belongs to a class of HIV therapies known as entry inhibitors that block HIV from entering into and infecting certain cells. The Company's product pipeline also includes Cytolin and CytoFeline. Cytolin is a mouse monoclonal antibody developed to identify a specific type of immune cell called a cytotoxic T cell, or cytotoxic T lymphocyte (CTL). CytoFeline is an anti-lymphocyte function-associated antigen-1 (LFA-1) antibody for the treatment of Feline Immunodeficiency Virus (FIV) infection. PRO 140 blocks HIV from entering a cell by binding to a molecule called C-C chemokine receptor type 5 (CCR5). The Company has finished Phase II clinical trials for PRO 140 with demonstrated antiviral activity in man.
Biotechnology Medical Specialties Antibodies Hiv Antiviral Drug Hiv/Aids Lentiviruses Viruses Animal Virology
Is CYDY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 0.71
52 Week Low 0.0552
Average Volume 394,161
200-Day Moving Average 0.4839
50-Day Moving Average 0.4446
20-Day Moving Average 0.4303
10-Day Moving Average 0.4281
Average True Range 0.0328
ADX 17.75
+DI 21.7781
-DI 10.4194
Chandelier Exit (Long, 3 ATRs ) 0.3956
Chandelier Exit (Short, 3 ATRs ) 0.4884
Upper Bollinger Band 0.4516
Lower Bollinger Band 0.409
Percent B (%b) 0.49
BandWidth 9.90007
MACD Line -0.0026
MACD Signal Line -0.003
MACD Histogram 0.0004
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.4564
Resistance 3 (R3) 0.4560 0.4468 0.4520
Resistance 2 (R2) 0.4468 0.4401 0.4470 0.4505
Resistance 1 (R1) 0.4384 0.4359 0.4338 0.4388 0.4491
Pivot Point 0.4292 0.4292 0.4269 0.4294 0.4292
Support 1 (S1) 0.4208 0.4225 0.4162 0.4212 0.4109
Support 2 (S2) 0.4116 0.4183 0.4118 0.4095
Support 3 (S3) 0.4032 0.4116 0.4080
Support 4 (S4) 0.4036